| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213208 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 30 Pages |
Abstract
High Ki67ratio in EGFRhigh:low is associated with worse clinical outcome in this subset of patients with anal cancer treated with chemoradiation on NRG Oncology RTOG 9811. Evaluation within a clinical trial will be required to determine whether patients with these tumor characteristics may specifically benefit from an EGFR-targeted therapeutic agent.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Corinne M. MD, Jennifer MS, Alexander PhD, Clement K. MD, Elizabeth N. MS, Susan P. PhD, Jaffer A. MD, Christopher H. MD, Lisa A. MD, Gordon S. MD, Lawrence B. MD, Kevin S. MD, Mark J. MD, David L. DO, Robert J. MD, Paul W. MD, Gerald W. MD, Chandan MD,